Baseline characteristics of sample by trial arm. by Stanley Carries (21172287)

“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”

CweL trial design. by Stanley Carries (21172287)

“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”

Participant Flow. by Stanley Carries (21172287)

“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”

Economic cost composition by arm and outcomes. by Stanley Carries (21172287)

“…There was a 1.32 unit (<i>p</i> = 0.085) decrease in depressive symptoms and a reduction in caregiver burden (β = -1.28, <i>p</i> = 0.020) in the intervention arm. …”

Continuous real-time VSMC E-modulus recordings following ADO or NO. by Zhongkui Hong (2215609)

Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome by X. Li (536560)

“…<div><p>Quercetin shows protective effects against hepatopulmonary syndrome (HPS), as demonstrated in a rat model. However, whether these effects involve pulmonary vascular angiogenesis in HPS remains unclear. …”

Fig 4 - by Zhen Chen (129176)

Generic model of infection under aggressive treatment (A) and containment (B). by Elsa Hansen (3737224)

Table2_Enhanced Transgene Expression by Optimization of Poly A in Transfected CHO Cells.DOCX by Xiao-yin Wang (11992034)

Table1_Enhanced Transgene Expression by Optimization of Poly A in Transfected CHO Cells.DOC by Xiao-yin Wang (11992034)

TOV-21G is a RAP80-null cell line. by Chunjing Bian (152551)

Optimal screening time point for a single colonoscopy program in the US. by Viktor Zaika (18611072)

“…Selected model parameters were increased and decreased by up to 50%, as indicated. The dashed line indicates the optimal schedule without parameter changes. …”

The effects of sleep loss on young drivers’ performance: A systematic review by Shamsi Shekari Soleimanloo (4405297)

“…Using those criteria, the quality of individual papers was calculated and the overall body of evidence for each driving outcome were assigned a quality ranking (from ‘very low’ to ‘high-quality’). …”

<i>Nrp 1</i> mediates the semaphorin-3A-induced inhibition of neurite outgrowth. by Pezhman Salehi (4528993)

“…<p>SGN explants were transfected with either 50nM <i>Nrp1</i> siRNA or scrambled siRNA, and treated with semaphorin-3A (250 ng/ml). …”

With progressing vaccination in the European Union, a slow but steady increase in freedom will be possible. However, premature lifting of NPIs considerably increases the total fata... by Simon Bauer (11378195)

“…The other extreme (Scenario 5) uses a strong initial reduction in contacts to allow long-term control at low case numbers. …”

Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence by Zachary J. Farino (2156665)

Parameters or variables used in the equations. by Brian Nils Lundstrom (14659973)

“…We have previously shown that low frequency EEG activity (<1 Hz) is decreased at the seizure onset zone (SOZ), while higher frequency activity (1–50 Hz) is increased. …”

S1 File - by Dong-Ju Park (17300283)

“…<div><p>Epigallocatechin gallate (EGCG) is a polyphenolic component of green tea that has anti-oxidative and anti-inflammatory effects in neurons. …”

S1 Data - by Dong-Ju Park (17300283)

“…<div><p>Epigallocatechin gallate (EGCG) is a polyphenolic component of green tea that has anti-oxidative and anti-inflammatory effects in neurons. …”

Histogram of the extracted parameters. by Qiuyu Du (20760848)

“…Logistic regression (n = 93) showed that a less steep contrast gradient (decreasing by 10 Hounsfield unit/%) was associated with a reduction in odds of the following short-term adverse outcomes: 48.1% for intensive care unit admission (odds ratio [OR] = 0.519, 95% confidence interval [CI]: 0.306–0.804), 29.3% for oxygen therapy >24 hours (OR = 0.707, 95% CI: 0.496–0.976), 60.6% for reperfusion therapy (OR = 0.394, 95% CI: 0.178–0.682), 57.5% for vasopressor therapy (OR = 0.425, 95% CI: 0.194–0.741), and 50.2% for PE-related death (OR = 0.498, 95% CI: 0.246–0.915). …”